The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
D000818:Animals; D000937:Antigen-Antibody Reactions; D002452:Cell Count; D002462:Cell Membrane / Q000276:immunology; D002470:Cell Survival; D002471:Cell Transformation, Neoplastic; D003601:Cytotoxicity Tests, Immunologic; D005455:Fluorescent Antibody Technique; D006084:Graft Rejection; D007106:Immune Sera; D007125:Immunogenetics; D007165:Immunosuppression Therapy; D008198:Lymph Nodes / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D008810:Mice, Inbred C57BL / Q000276:immunology; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000276:immunology* / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013997:Time Factors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D007106:Immune Sera